Cartesian Therapeutics, Inc. (RNAC) Earnings
NASDAQ·Healthcare·Biotechnology
$9.61
+19.17%
Mkt Cap $234.55M
EPS — Estimate vs Actual
Mkt Cap
$234.55M
P/E
—
Fwd P/E
—
P/S
64.45
Rev TTM
—
EPS TTM
-$5.02
NASDAQ·Healthcare·Biotechnology
$9.61
+19.17%
Mkt Cap $234.55M
Mkt Cap
$234.55M
P/E
—
Fwd P/E
—
P/S
64.45
Rev TTM
—
EPS TTM
-$5.02